Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
34,100
Employees34,100
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
34,100
Employees34,100

BMY Key Statistics

Market cap
96.41B
Market cap96.41B
Price-Earnings ratio
18.04
Price-Earnings ratio18.04
Dividend yield
5.08%
Dividend yield5.08%
Average volume
12.34M
Average volume12.34M
High today
$48.23
High today$48.23
Low today
$47.26
Low today$47.26
Open price
$48.08
Open price$48.08
Volume
10.72M
Volume10.72M
52 Week high
$63.33
52 Week high$63.33
52 Week low
$41.61
52 Week low$41.61

BMY News

TipRanks 8h
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game Changer?

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 1d
Bristol-Myers Squibb’s Promising Study on Advanced Solid Tumors

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 1d
Bristol-Myers Squibb and Pfizer Stocks Jump on Eliquis Drug Discount

Bristol-Myers Squibb (BMY) and Pfizer (PFE) have revealed plans to sell their Eliquis blood thinner directly to patients at a discounted price, reports The Wall...

Analyst ratings

71%

of 28 ratings
Buy
25%
Hold
71.4%
Sell
3.6%

More BMY News

Benzinga 4d
Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?

Bristol-Myers Squibb & Co. BMY is gearing up to announce its second-quarter 2025 earnings on July 31, with expectations for adjusted earnings of $1.585 per shar...

Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.